Traders bought shares of Novadaq Technologies Inc (NASDAQ:NVDQ) (TSE:NDQ) on weakness during trading on Monday. $12.72 million flowed into the stock on the tick-up and $1.37 million flowed out of the stock on the tick-down, for a money net flow of $11.35 million into the stock. Of all stocks tracked, Novadaq Technologies had the 28th highest net in-flow for the day. Novadaq Technologies traded down ($0.05) for the day and closed at $11.59

NVDQ has been the subject of several research analyst reports. Scotiabank reaffirmed an “outperform” rating and set a $18.00 target price on shares of Novadaq Technologies in a research note on Wednesday, April 26th. Zacks Investment Research raised Novadaq Technologies from a “sell” rating to a “hold” rating in a research note on Tuesday, May 9th. Stifel Nicolaus reaffirmed a “buy” rating and set a $10.00 target price on shares of Novadaq Technologies in a research note on Friday, June 2nd. Northland Securities reaffirmed a “hold” rating and set a $11.75 target price on shares of Novadaq Technologies in a research note on Monday, June 19th. Finally, Wedbush downgraded Novadaq Technologies from an “outperform” rating to a “neutral” rating in a research note on Monday, June 19th. One analyst has rated the stock with a sell rating, twelve have issued a hold rating and two have assigned a buy rating to the company. Novadaq Technologies presently has a consensus rating of “Hold” and an average price target of $11.86.

The stock’s market capitalization is $670.16 million. The company’s 50-day moving average is $11.71 and its 200-day moving average is $8.49.

A number of institutional investors have recently modified their holdings of the company. Gamco Investors INC. ET AL purchased a new position in shares of Novadaq Technologies during the second quarter valued at about $145,000. Virtu Financial LLC purchased a new position in shares of Novadaq Technologies during the second quarter valued at about $157,000. Quantitative Systematic Strategies LLC purchased a new position in shares of Novadaq Technologies during the first quarter valued at about $169,000. Envestnet Asset Management Inc. boosted its position in shares of Novadaq Technologies by 12.9% in the first quarter. Envestnet Asset Management Inc. now owns 25,374 shares of the medical research company’s stock valued at $197,000 after buying an additional 2,898 shares in the last quarter. Finally, Wolverine Trading LLC purchased a new position in shares of Novadaq Technologies during the second quarter valued at about $254,000. 86.47% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This story was first posted by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.watchlistnews.com/investors-buy-novadaq-technologies-inc-nvdq-on-weakness/1488004.html.

Novadaq Technologies Company Profile

NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Receive News & Ratings for Novadaq Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.